Read More ➲

Press

Brite Bio News and Publications







Publications

Article Title
Description
BriteBio, Inc. Awarded a Phase I SBIR Grant
For the Development of Toxicological Platforms utilizing Human Pluripotent Cells Download : View

Note: The download attribute is not supported in Edge version 12, IE, Safari or Opera version 12 (and earlier).